Publication: Possible mechanisms of vasorelaxation for 5,7-dimethoxyflavone from Kaempferia parviflora in the rat aorta
1
0
Issued Date
2010
Resource Type
File Type
application/pdf
ISSN
0951418X
DOI
Other identifier(s)
2-s2.0-78649435662
Rights Holder(s)
มหาวิทยาลัยศรีนครินทรวิโรฒ
Bibliographic Citation
Phytotherapy Research. Vol 24, No.10 (2010), p.1520-1525
Suggested Citation
Tep-Areenan P., Sawasdee P., Randall M. Possible mechanisms of vasorelaxation for 5,7-dimethoxyflavone from Kaempferia parviflora in the rat aorta. Phytotherapy Research. Vol 24, No.10 (2010), p.1520-1525. doi:10.1002/ptr.3164 Retrieved from: https://hdl.handle.net/20.500.14740/7541
Author(s)
Abstract
The present study investigated the vascular effects of 5,7-dimethoxyflavone (DMF), isolated from the rhizomes of Kaempferia parviflora (KP), on rat isolated aortic rings and its possible mechanisms. DMF (1-100 μm) caused concentration-dependent relaxations in aortic rings precontracted with methoxamine. This effect was significantly reduced by removal of the endothelium, and after pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 300 μm), indomethacin (10 μm) and 1H-[1,2,4]oxadiazolo-[4, 3-a]quinoxalin-1-one (ODQ, 10 μm), but not 9-(tetrahydro-2-furanyl)-9H- purine-6-amine (SQ22536, 100 μm). Relaxant responses to DMF were significantly inhibited by high KCl (60 mm) in both endothelium-intact and -denuded rings. In addition, the relaxations to DMF were significantly reduced by pretreatment with tetraethylammonium (TEA, 5 mm), glibenclamide (10 μm), 4-aminopyridine (1 mm) or barium chloride (10 μm). Preincubation with DMF (10 and 100 μm) for 30 min significantly inhibited the contractile responses to CaCl2 in a Ca2+-free, high K+ buffer. The present study demonstrated that DMF causes endothelium-dependent relaxation that is partly mediated by NO-cGMP and cyclooxygenase pathways. Interestingly, DMF-induced responses are mainly due to increasing K+ efflux, and inhibition of Ca2+ influx from the extracellular space. The vasodilator effects of DMF provide experimental support for the potential use of KP as a medical plant in the treatment of cardiovascular diseases. © 2010 John Wiley & Sons, Ltd.
Subject(s)
1h 1,2,4 oxadiazolo[4,3 a]quinoxalin 1 one
4 aminopyridine
5,7 dimethoxyflavone
Barium chloride
Buffer
Calcium chloride
Flavone
Glibenclamide
Indometacin
Methoxamine
N(g) nitroarginine methyl ester
Potassium chloride
Tetrylammonium
Unclassified drug
Animal cell
Animal experiment
Article
Calcium transport
Cardiovascular disease
Controlled study
Endothelium
Extracellular space
Male
Medicinal plant
Nonhuman
Potassium transport
Rat
Rhizome
Vascular ring
Vasodilatation
Animals
Aorta
Calcium
Cyclic GMP
Flavonoids
Male
Nitric Oxide
Rats
Rats, Wistar
Rhizome
Vasodilation
Zingiberaceae
Kaempferia parviflora
Rattus
4 aminopyridine
5,7 dimethoxyflavone
Barium chloride
Buffer
Calcium chloride
Flavone
Glibenclamide
Indometacin
Methoxamine
N(g) nitroarginine methyl ester
Potassium chloride
Tetrylammonium
Unclassified drug
Animal cell
Animal experiment
Article
Calcium transport
Cardiovascular disease
Controlled study
Endothelium
Extracellular space
Male
Medicinal plant
Nonhuman
Potassium transport
Rat
Rhizome
Vascular ring
Vasodilatation
Animals
Aorta
Calcium
Cyclic GMP
Flavonoids
Male
Nitric Oxide
Rats
Rats, Wistar
Rhizome
Vasodilation
Zingiberaceae
Kaempferia parviflora
Rattus
